The influence of mTOR inhibitors on immunity and the relationship to post-transplant malignancy

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• The role of mammalian target of rapamycin (mTOR) in immunity is complex, extending beyond simple immunosuppression.
• mTOR integrates signals crucial for T cells, B cells, and antigen-presenting cells.

Purpose of the Study:

• To review the multifaceted role of mTOR in immune cell development and function.
• To examine mTOR's influence in the context of organ transplant rejection and post-transplant malignancy.

Main Methods:

• Literature review of recent data on mTOR's immunological functions.
• Analysis of mTOR's signaling pathways in immune cells.
• Contextualization within transplant immunology and oncology.

Main Results:

• mTOR inhibition can paradoxically promote or inhibit immune responses based on antigenic stimulus and microenvironment.
• mTOR signaling dictates distinct immune outcomes for different foreign entities (e.g., transplants vs. tumors).
• mTOR is central to shaping adaptive and innate immune responses.

Conclusions:

• Understanding mTOR's intricate regulation of immune cells is critical for managing transplant rejection.
• mTOR's complex role necessitates further investigation for therapeutic strategies against post-transplant malignancy.
• mTOR acts as a key integrator of immune signals, influencing diverse immunological outcomes.